Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ovid Therapeutics Inc.

1.49
-0.1100-6.87%
Post-market: 1.520.0300+2.01%19:58 EDT
Volume:3.08M
Turnover:4.68M
Market Cap:105.95M
PE:-2.78
High:1.63
Open:1.63
Low:1.48
Close:1.60
52wk High:2.01
52wk Low:0.2425
Shares:71.11M
Float Shares:59.52M
Volume Ratio:2.60
T/O Rate:5.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5359
EPS(LYR):-0.3663
ROE:-52.77%
ROA:-26.71%
PB:1.90
PE(LYR):-4.07

Loading ...

Nov 08, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 10, 2022

Major Issues Report

8-K - Current report
May 11, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 16, 2022

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 15, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 03, 2022

Major Issues Report

8-K - Current report
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]